TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.
|2||Active, not recruiting||
De-intensification of Radiation and Chemotherapy for Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma
Active, not recruiting
Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
Dose Escalation Versus Standard in Laryngopharyngeal Cancers
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
Quarterback 2 - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer
The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer
Cabazitaxel - PF Induction Chemotherapy
† Study has passed its completion date and status has not been verified in more than two years.